James L. Herman
CIK: 0001572342
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CPIX
CUMBERLAND PHARMACEUTICALS INC
Officer
Discretionary Trading P&L
Holdings
About Herman James L
Herman James L (SEC CIK 0001572342) files insider reports with the SEC as VP and Chief Compliance Office of CUMBERLAND PHARMACEUTICALS INC (CPIX).
Signal8 holds 2 ownership filings by Herman James L, all Form 4s, filed between Mar 18, 2025 and Mar 20, 2026. Those filings report 2 transactions, from Mar 17, 2025 to Mar 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Herman James L's filings is in NASHVILLE, TN.
Recent filings by Herman James L
Other insiders filing for CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Brown Martin S JR, Director
- Galante Joseph C, Director
- Jones James, Director
- Krogulski Kenneth, Director
- Young Caroline, Director
- Anthony Todd M., Vice Pres Organizational Dev